Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Agilent Technologies, Inc. A

Healthcare  —  Diagnostics & Research
172.79 (0.05) (0.03%) as of 25 Sep
Market cap
$49.0B
P/E
33.9×
S&P 500 Member Dividend Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Agilent Technologies, Inc. (A) EV/EBITDA

As of 25 September 2026, Agilent Technologies, Inc. (A) trades at a EV/EBITDA of 26.5×. Over the past ten years it has ranged from 13.1× (September 2015) to 35.6× (September 2021); the current reading is higher than 85% of that period. That is above the Diagnostics & Research industry median of 25.2× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 24.2× 6.25%
FY2024 22.8× 17.26%
FY2023 19.5× (12.55%)
FY2022 22.2× (24.12%)
FY2021 29.3× 1.41%
FY2020 28.9× 40.88%
FY2019 20.5× 12.34%
FY2018 18.3× (11.48%)
FY2017 20.6× 28.58%
FY2016 16.0× 1.45%

Quarterly

Period EV/EBITDA Change
Jul 2026 21.4× 15.99%
Apr 2026 18.5× (18.92%)
Jan 2026 22.8× (6.03%)
Oct 2025 24.2× 21.82%
43 more quarters

Against its own ten years

Low 13.1× High 35.6×
Ten-year median 20.9×
Current reading's percentile 85

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
IQV IQVIA Holdings Inc. compare 17.3×
MTD Mettler-Toledo International, Inc. compare 24.9×
IDXX IDEXX Laboratories, Inc. compare 25.6×
A Agilent Technologies, Inc. 26.5×
ILMN Illumina, Inc. compare 36.0×
WAT Waters Corporation compare 49.8×
Diagnostics & Research industry median 25.2×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on A